Affordable Access

Publisher Website

Anti-estrogenic effects of contraceptive progestins on the dynamics of gonadotropin release

Authors
Journal
Contraception
0010-7824
Publisher
Elsevier
Publication Date
Volume
25
Issue
6
Identifiers
DOI: 10.1016/0010-7824(82)90063-4
Disciplines
  • Pharmacology

Abstract

Abstract The hypophysiotropic effects of ethinylestradiol (EE) alone and in combination with three different progestins at various doses were assessed in 39 normal women. The compounds were given orally for 7 to 21 days. Serum LH and FSH were measured before and after GnRH double stimulation (2 × 25 μg i.v. at a two-hour interval); the ratio between second and first response served as an index of the gonadotropin-synthesis capacity. Compared to pretreatment early follicular phase controls (LH and FSH ratios of 1.3 and 1.4), administration of 40 and 50 ug of EE daily elicited a significant amplification of LH and FSH synthesis (LH ratios of 2.2 and 3.3; FSH ratios of 2.8 and 3.3). By contrast, 80 μg of EE daily caused little change. The EE-induced rise of pituitary responsiveness to GnRH could be counteracted by the addition of progestins. The degree of inhibition was dependent on the type and dose of the progestational compound. It is concluded that the standardized GnRH double stimulation technique may serve as a pharmacodynamic model to quantitate the estrogenic and anti-estrogenic effects of contraceptive steroids at the pituitary level.

There are no comments yet on this publication. Be the first to share your thoughts.